FTSE 100 Live 02 June: Vodafone completes Three merger, Asia stocks struggle
What happens when you stop taking weight loss drugs like Mounjaro and Ozempic?
What happens when you stop taking weight loss drugs like Ozempic?
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scottish Sun
2 hours ago
- Scottish Sun
I recovered from booze & drug addiction then piled on 3 stone – Mounjaro was the only thing that helped
Plus, the dangers of the jab SILVER BULLET I recovered from booze & drug addiction then piled on 3 stone – Mounjaro was the only thing that helped CAT Sims has opened up about turning to Mounjaro after quitting booze and drugs lead her turning to food and piling on three stones. Author and podcaster Cat, 43, from London, hailed the weight loss jab as 'rehab for food' and praised it for being a 'silver bullet.' Advertisement 8 Cat Sims has opened up about using Mounjaro after battling with 'food addiction' Credit: Instagram 8 Cat with her husband Jimmy and their two daughter Billie and Bo Credit: Supplied Cat has previously opened up about battling an alcoholic and drug addiction - but managed to kick the habit of having a bottle of wine a night and taking cocaine regularly. However, she then struggled with food. Speaking on the podcast, Made by Mammas, she candidly shared that she is 'all or nothing' and food is a 'big issue for her.' Cat, who is married to husband Jimmy and has two daughters, Billie and Bo, explained: 'I think actually that was probably my first addiction. Advertisement More on Mounjaro JAB BACKLASH Mum on Mounjaro slated as toddler pretends to inject herself with fat jabs 'But for me, I'm sure there are people who can balance who can moderate. I do not have that gene. 'I've recently started Mounjaro, I've recently started the weight loss jabs. 'I was three stone heavier than I was when I gave up booze. 'I think people think if you give up booze you're going to lose a little weight. Advertisement 'I lost nothing. I just went straight into food and chocolate and sugar.' She then explained how Mounjaro has helped her 'food addiction', and said: 'For me it's like rehab for food addiction. I was depressed and exhausted before Mounjaro - I've lost 4 stone but have had FOUL side effects, including eggy burps 'You're locked down and while you're there you do all the work, so that when you come out of rehab you can do it on your own. 'And that's what Mounjaro is for me.' Advertisement Cat shared how she feels like her food addiction is now gone thanks to the controversial weight loss jab. 8 Cat Sims opened up on Made by Mammas: The Podcast Credit: Cat Sims - Made by Mammas: The Podcast 8 Cat Sims has bravely spoken out about battling her booze addiction Credit: Tash Busta 8 The mum-of-two has been sober since 26 November 2021 Credit: Supplied Advertisement She added: 'I have no cravings for the crappy food or the ultra processed stuff. 'It was always a difficult thing because with booze and alcohol I was always like I can just abstain, I don't have to have those things, but food, I can't just not eat. 'But now I think doing the work I'm doing while I'm on the injections has made me realise that I can abstain from the ultra processed stuff. 'There are side effects, as there are with any drug or medication or anything that you put into you that isn't naturally supposed to be, but for me, it's been a silver bullet in terms of helping me manage what is essentially a food addiction, you know, and also I'm perimenopausal.' Advertisement 8 Cat found that she had a 'habit of drinking to blackout' Credit: Supplied 8 Cat thought she was 'living for the moment' by heading out for drinks Credit: Supplied 8 Cat is now living a calm and peaceful sober life Credit: Supplied MOUNJARO TAKEOVER Mounjaro injections are licensed for patients with type 2 diabetes and are administered every seven days. Advertisement They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over). The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber. But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks. Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK. Advertisement
The Sun
2 hours ago
- The Sun
I recovered from booze & drug addiction then piled on 3 stone – Mounjaro was the only thing that helped
CAT Sims has opened up about turning to Mounjaro after quitting booze and drugs lead her turning to food and piling on three stones. Author and podcaster Cat, 43, from London, hailed the weight loss jab as 'rehab for food' and praised it for being a 'silver bullet.' 8 8 Cat has previously opened up about battling an alcoholic and drug addiction - but managed to kick the habit of having a bottle of wine a night and taking cocaine regularly. However, she then struggled with food. Speaking on the podcast, Made by Mammas, she candidly shared that she is 'all or nothing' and food is a 'big issue for her.' Cat, who is married to husband Jimmy and has two daughters, Billie and Bo, explained: 'I think actually that was probably my first addiction. 'But for me, I'm sure there are people who can balance who can moderate. I do not have that gene. 'I've recently started Mounjaro, I've recently started the weight loss jabs. 'I was three stone heavier than I was when I gave up booze. 'I think people think if you give up booze you're going to lose a little weight. 'I lost nothing. I just went straight into food and chocolate and sugar.' She then explained how Mounjaro has helped her 'food addiction', and said: 'For me it's like rehab for food addiction. 'You're locked down and while you're there you do all the work, so that when you come out of rehab you can do it on your own. 'And that's what Mounjaro is for me.' Cat shared how she feels like her food addiction is now gone thanks to the controversial weight loss jab. 8 8 8 She added: 'I have no cravings for the crappy food or the ultra processed stuff. 'It was always a difficult thing because with booze and alcohol I was always like I can just abstain, I don't have to have those things, but food, I can't just not eat. 'But now I think doing the work I'm doing while I'm on the injections has made me realise that I can abstain from the ultra processed stuff. 'There are side effects, as there are with any drug or medication or anything that you put into you that isn't naturally supposed to be, but for me, it's been a silver bullet in terms of helping me manage what is essentially a food addiction, you know, and also I'm perimenopausal.' 8 8 8 MOUNJARO TAKEOVER Mounjaro injections are licensed for patients with type 2 diabetes and are administered every seven days. They are also available to assist those who are clinically obese (with a Body Mass Index of 30 or over). The drugs, which have been widely regarded as 'fat jabs', can be prescribed by a practitioner - such as a doctor, nurse or a pharmacist-independent prescriber. But increasingly, we are seeing more and more people buying them through online pharmacies, without sufficient checks. Not only this, but recently, figures from the Medicines and Healthcare products Regulatory Agency revealed that fat jabs had been linked to 82 deaths across the UK. Everything you need to know about fat jabs Weight loss jabs are all the rage as studies and patient stories reveal they help people shed flab at almost unbelievable rates, as well as appearing to reduce the risk of serious diseases. Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for years while Mounjaro (tirzepatide) is a newer and more powerful addition to the market. Mounjaro accounts for most private prescriptions for weight loss and is set to join Wegovy as an NHS staple this year. How do they work? The jabs work by suppressing your appetite, making you eat less so your body burns fat for energy instead and you lose weight. They do this my mimicking a hormone called GLP-1, which signals to the brain when the stomach is full, so the drugs are officially called GLP-1 receptor agonists. They slow down digestion and increase insulin production, lowering blood sugar, which is why they were first developed to treat type 2 diabetes in which patients' sugar levels are too high. Can I get them? NHS prescriptions of weight loss drugs, mainly Wegovy and an older version called Saxenda (chemical name liraglutide), are controlled through specialist weight loss clinics. Typically a patient will have to have a body mass index (BMI) of 30 or higher, classifying them as medically obese, and also have a weight-related health condition such as high blood pressure. GPs generally do not prescribe the drugs for weight loss. Private prescribers offer the jabs, most commonly Mounjaro, to anyone who is obese (BMI of 30+) or overweight (BMI 25-30) with a weight-related health risk. Private pharmacies have been rapped for handing them out too easily and video calls or face-to-face appointments are now mandatory to check a patient is being truthful about their size and health. Are there any risks? Yes – side effects are common but most are relatively mild. Around half of people taking the drug experience gut issues, including sickness, bloating, acid reflux, constipation and diarrhoea. Dr Sarah Jarvis, GP and clinical consultant at said: 'One of the more uncommon side effects is severe acute pancreatitis, which is extremely painful and happens to one in 500 people.' Other uncommon side effects include altered taste, kidney problems, allergic reactions, gallbladder problems and hypoglycemia. Evidence has so far been inconclusive about whether the injections are damaging to patients' mental health. Figures obtained by The Sun show that, up to January 2025, 85 patient deaths in the UK were suspected to be linked to the medicines.
NBC News
7 hours ago
- NBC News
Wegovy use among U.S. teens up 50% as obesity crisis worsens
American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in its use for young people with obesity, new data shared with Reuters shows. The average rate of teens beginning treatment with the highly effective Novo Nordisk drug grew 50% last year to 14.8 prescriptions per 100,000 adolescents, according to an analysis by health data firm Truveta. That's up from a rate of 9.9 prescriptions per 100,000 in 2023, the first full year that Wegovy was available to children aged 12 and older. The average rate climbed further during the first three months of this year, reaching 17.3 new prescriptions per 100,000. That still represents a minute fraction of the estimated 23,000 out of every 100,000 teens in the country who are living with obesity, and is far slower than the uptake among U.S. adults. 'It's promising that more young people are using these medications, but it's still a very small percentage of patients with severe obesity that are getting access to them,' said Dr. Cate Varney, director of obesity medicine at the University of Virginia Health system. 'When lifestyle changes alone are insufficient, we need these additional tools.' For its analysis, Truveta reviewed the electronic health records of 1.3 million patients ages 12 through 17. The data covers 30 U.S. health systems with more than 900 hospitals and 20,000 clinics across the country. The analysis did not include other GLP-1 drugs, including Novo's Ozempic and Eli Lilly's LLY.N Zepbound, which are not approved to treat obesity in adolescents, or compounded versions of these therapies. Wegovy became an option to treat adolescents in late 2022 after decades in which the conventional approaches of diet, exercise and counseling largely failed. About 8 million American teens, or 23% of people ages 12 to 19, have obesity, up from 5% in 1980, according to U.S. government data. Young people with obesity run a much higher risk of developing chronic, costly, life-shortening conditions like type 2 diabetes and cardiovascular and liver diseases. In January 2023, the American Academy of Pediatrics strongly recommended that doctors provide weight-loss drugs to children with obesity starting at age 12. Yet the medical community has not uniformly embraced GLP-1s for adolescents. Some doctors are hesitant because the drugs' long-term safety for children during a critical phase of development is unknown, and the treatments may need to be used indefinitely. Overall, there are limited options for many teens and their parents because insurance plans often do not cover any treatment for obesity, including intensive behavioral counseling, visits with a dietician or the new GLP-1 medications. At Nemours Children's Hospital in Wilmington, Delaware, the Healthy Weight and Wellness Clinic treated about 2,000 adolescent patients last year. About 25% were prescribed Wegovy or another GLP-1 medication, said Dr. Thao-Ly Phan, the clinic's medical director. The number of adolescents with a GLP-1 prescription nearly doubled from 2023. On average, their patients taking a GLP-1 drug lost 15 pounds (6.8 kg) within 6 to 12 months, and nearly 30 pounds after more than a year. For many of the other patients, the medications were not an option, either because of insurance hurdles or concern within families about potential risks. Other teens opted for lifestyle changes or older, cheaper weight-loss drugs, with some success. 'It is important for us to continue to monitor and better understand outcomes from the medications — both positive and negative — before widespread use,' Phan said. U.S. Health Secretary Robert F. Kennedy Jr. has criticized the idea of prescribing Ozempic or Wegovy widely to children to treat obesity. In a federal health report he released last month, GLP-1 drugs were cited as an example of the 'overmedicalization of our kids.' It noted a lack of 'long-term safety data, raising the specter of unforeseen problems that interrupt, damage, or impair metabolism and growth development.' Novo in a statement said semaglutide, the active ingredient in Wegovy and Ozempic, 'did not appear to affect growth or pubertal development' during its clinical trials involving teens. For many adults, Novo said, obesity starts in childhood or adolescence, and 'we are confident in the proven safety and efficacy of our GLP-1 medicines.' Eli Lilly's weight-loss drug Zepbound is in late-stage clinical trials for use by adolescents. Lilly told Reuters that 'there has been no evidence to date suggesting impairment in growth or metabolism' from GLP-1 medications. Dr. Robert Siegel, a pediatrician and director of the Center for Better Health and Nutrition at Cincinnati Children's Hospital, said about 15% of adolescents being treated there were prescribed Wegovy or a similar GLP-1 medication from July 2021 to July 2023. They include patients being treated for type 2 diabetes for which the GLP-1 drugs were originally developed. Siegel said he prefers to start teens on three to six months of intensive lifestyle management before even considering medication. While obesity specialists can help navigate potential risks from the drugs, many primary-care providers need more training, he said. They may not have the equipment to monitor for the loss of muscle mass — a side effect of these medicines — or lack the resources to work with families over an extended period on healthier eating and exercise. 'These medications are likely to be needed for a very long time to maintain weight,' Siegel said, 'and we only have a relatively short-term experience with them.'
